Corrections or additions?
Prepared for August 30, 2000 edition of U.S. 1 Newspaper. All
ITXC Expands Into Voice-Enabled Web
600 College Road East, Princeton 08540. Tom Evslin, CEO. 609-419-1500;
fax, 609-419-1511. Home page: www.itxc.com
ITXC’s purchase of a private voice-enabled applications company,
will help to develop its services for "E-calling," the
successor to phone calling. Based in Beaverton, Oregon, eFusion will
be a wholly-owned subsidiary of ITXC, which will pay for the buy with
cash on hand.
The Oregon firm has products with a much higher margin than basic
telephony services and therefore with a bigger potential for profit.
"Push to Talk" can voice-enable web sites, provide live human
interaction with call centers, and spur browsers to become buyers.
"Suite Adeline" offers Internet call waiting, voice mail,
and follow-me services as part of PC-based call management
With ITXC’s E-calling, users can be reached with a single ID no matter
where they travel. This "reach me" service integrates phones,
wireless, and computers, and can be combined with web browsing or
"The eFusion team is extremely innovative and productive,"
says Tom Evslin, CEO of ITXC. "The Oregon facility will be the
headquarters for our E-calling E-commerce services as well as the
location of other activities." Ajit Pendse, chairman of eFusion,
will be an executive vice president at ITXC. Luis F. Machuca, formerly
director of marketing at Intel and now eFusion’s president and COO,
will be executive vice president and general manager of the
In addition to excellent patent protection, eFusion has been selling
products to such companies as US West, Duro Communications (a major
ISP in southeastern United States) and Cameraworld.com (an online
reseller). The deal is expected to close by the end of the year.
08691. Joseph Mo, chairman, CEO, and president. 609-208-9688; fax,
609-208-1868. Home page: www.nexmed.com
NexMed, developers and makers of sexual dysfunction products, has
made progress toward entering the market in China with a paper
August 27-30 in Beijing. The report told about 160 men with erectile
dysfunction in a double blind, placebo-controlled study at four
in Beijing. They were asked to use the medication — Nexmed’s
— "as needed" over a four-week take home period, and they
were supposed to attempt intercourse as many times as possible but
no more than once daily.
The dropout rate was low, under two percent, and the prescription
treatment had an effective rate of 67.5 percent versus 13 percent
for the placebo. Of those using the active cream, 75 percent improved
their erections over the therapy period versus under 20 percent of
the placebo group.
The erectile dysfunction market is estimated to be a multi-billion
business. NexMed Pharmaceuticals has applied to manufacture and market
its cream in China under the name Befar. NexMed is also constructing
a a 32,5000 square foot manufacturing facility on Twin Rivers Drive.
Center at Forsgate, CN 4000, Cranbury 08512. Joseph S. Taylor,
and chief executive officer. 732-521-2900; fax, 609-395-8289.
In its busiest construction year ever, the 21-year-old Matrix
Group is building 3 million square feet of industrial construction,
including a speculative building in the CenterPoint at 8A industrial
park. The new warehouse and distribution center, at 24 Englehard
is scheduled to be ready to take one or more tenants by the end of
the year. It has a 32-foot ceiling clearance and 70 "cross
bays. Among the other tenants of CenterPoint are Volkswagen of
Siemens Medical Systems, and Sony Corporation of America.
"Based on the strength of the market, and based on the perennial
appeal of CenterPoint at8A, we have absolute confidence in the
of this property," says Jim Murray, development project manager
Matrix also has five current deals at its $200 million "Big
development at the Northeast Business Park, at the Exit 7A Interchange
of the New Jersey Turnpike. The three announced projects are a 1
foot warehousing and distribution facility for Seaman’s Furniture
Company, a 550,000 square-foot distribution center for Lifetime Hoan
Corporation, and a 150,000 square-foot warehouse and manufacturing
facility for Denby Associates. Two more deals are pending. The first
customer in Northeast Business Park was the 11-acre northeast service
center for Amway in 1997.
Princeton 08540. Tim Crandle, president North America. 609-520-1935;
fax, 609-520-8512. Home page: www.telelogic.com
The global company headquartered in Malmo, Sweden, paid $115 million
in stock for Quality Systems & Software (QSS), a Virginia-based,
company that offers requirements managements solutions
The purchase makes Telelogic the largest provider of such tools for
real-time applications and doubles its sales capacity in the United
States. Its North American headquarters is at Forrestal Village, where
it has about 15 employees on site.
"Our ambition is to be the partner of choice for companies and
engineers developing advanced software," says Anders Lidbeck,
QSS has DOORS, the first enterprise-wide requirements management suite
for all types of users. For project compliance it can capture, link,
trace, analyze, and manage a variety of textual and graphical
Suite 206, Princeton 08540. Donald L. Drakeman, president.
fax, 609-430-2850. Also, 1545 Route 22 East, Box 953, Annandale
908-713-6001; fax, 908-713-6002. Home page: www.medarex.com
Medarex will collaborate with Athersys Inc. to apply its HuMAb-Mouse
technology to Athersys’ RAGE (Random Activation of Gene Expression)
technology. "The combination of Athersys’ proteomics expertise
with our human antibody technology is a logical match for the
development of new therapeutics," says Donald L. Drakeman,
and CEO of Medarex.
Based in Cleveland, Ohio, Athersys develops therapeutic products to
treat significant and life threatening diseases (www.athersys.com).
Medarex develops monoclonal anti-body based therapeutics for similar
purposes. Among Medarex’ products in clinical development are those
to combat cancer, prevent secondary cataracts, and treat acute myeloid
Donald Drakeman and his wife, Lisa Drakeman, will be inducted into
the High Tech Hall of Fame at a Biotechnology Council of New Jersey
dinner on Wednesday, October 18, at the Garden State Arts Center in
Holmdel (www.njhightech.org, call 609-890-3185). Lisa Drakeman
is chief executive officer of Genmag A/S, a Copenhagen-based
firm that develops monoclonal antibodies to treat a wide range of
Last month Cytogen hoped to buy Massachusetts-based
Advanced Magnetics for $60 million in Cytogen stock. That deal is
off — perhaps because Wall Street judged the merger too time
and expensive — but Cytogen walks away with the rights to market
and sell Advanced Magnetic’s prize product.
Advanced Magnetics (AVM, www.advancedmagnetics.com) develops and
MRI contrast agents useful for cancer and liver disease; it has a
manufacturing facility and an R&D fund of $19.5 million. Cytogen
www.cytogen.com), based on College Road, needs R&D money and could
use manufacturing space, but it has a full marketing team selling
similar products to radiologists.
The near-term benefits of the merger, both sides say, were a subject
of "mutual concern," but the two companies did want to team
up on marketing and supply arrangements.
Cytogen turned profitable for the first time in 18 years early last
year. It will get exclusive United States marketing rights to
a magnetic resonance imaging contrast agent for detecting lymph node
cancer that has been deemed approvable by the Food and Drug
It will get similar rights to a next-generation product for oncology
"The first place cancer spreads to is the lymph nodes. Instead
of taking a biopsy, you can give an injection and 24 hours later take
a picture," says Richard Krawiec, Cytogen’s vice president of
investor relations. Two similar Advanced Magnetics products are on
the market, and more are in the pipeline.
Advanced Magnetics is scheduled to receive 1.5 million shares of
stock (about $13 million at current prices) plus another $500,000
upon reaching milestones. Advanced Magnetics has 35 employees, most
at a manufacturing facility in Cambridge, but 10 at a clinical and
regulatory affairs office at the Carnegie Center.
CN 5308, Princeton 08543-5308. H. Joseph Reiser, CEO. 609-987-8200;
fax, 609-750-8130. Home page: www.cytogen.com
Suite 202, Princeton 08540-6232. Leonard M. Baum, senior vice
609-520-8505; fax, 609-520-0620.
Suite 9 Forsgate Technical Center, Jamesburg 08831. Ted Young,
service manager. 609-395-7728; fax, 609-395-8121. Home page:
SPX closed this office on July 21 and consolidated operations to its
Kalamazoo headquarters at 8001 Angling Road, Portage, MI 49024,
fax, 800-809-1234. Some employees will stay in this area and working
from their home, and Ted Young will work from a Virginia office. The
firm sells emission testing equipment for auto diagnostics.T
manager with Princeton Air Conditioning Co. on Everett Drive.
Corrections or additions?
This page is published by PrincetonInfo.com
— the web site for U.S. 1 Newspaper in Princeton, New Jersey.